| Compound | 3-o-(cis-p-coumaroyl)-maslinic acid |
| NPACT-Id | NPACT01083 |
| IUPAC | - |
| Synonyms | 11-hydroxy-10-[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
| PubChem Id | 5316120 |
| Class | Terpenoids |
| In-vitro anticancer activity | 6 cancer cell lines |
| In-Vivo anticancer activity | No |
| Targets | No targets found |
| Properties | Physical Elemental Topological |
| InChi Key | KWLOAKAXMOYBRK-GDNBJRDFSA-N |
| InChi | 1S/C39H54O6/c1-34(2)18-20-39(33(43)44)21-19-37(6)26(27(39)22-34)13-14-30-36(5)23-28(41)32(35(3,4)29(36)16-17-38(30,37)7)45-31(42)15-10-24-8-11-25(40)12-9-24/h8-13,15,27-30,32,40-41H,14,16-23H2,1-7H3,(H,43,44)/b15-10- |
| SMILES | O(C1C(C2C(C3C(C4(C(=CC3)C3C(CC4)(CCC(C3)(C)C)C(=O)O)C)(CC2)C)(CC1O)C)(C)C)C(=O)/C=Cc1ccc(O)cc1 |
|
SMART | [H]OC(=O)[C@]12C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])C(=C([H])C([H])([H])[C@@]4([H])[C@]5(C([H])([H])[H])C([H])([H])[C@]([H])(O[H])[C@@]([H])(OC(=O)C([H])=C([H])C6=C([H])C([H])=C(O[H])C([H])=C6[H])[C@](C([H])([H])[H])(C([H])([H])[H])[C@@]5([H])C([H])([H])C([H])([H])[C@]34C([H])([H])[H])[C@]1([H])C([H])([H])[C@](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H] |
| CAS No. | - |
|
Structure
Download | 
|
| Cross Refrence in other databases |
| Super Natural | - |
| CTD | - |
| HIT | - |
| NCI-60 GI50 data | - |
| Suppliers | ABI Chem, |
| Drug-Likeliness Filters | Lipinski's rule of five | No |
| Ghose filter | No |
| Veber filter | Yes |
| Muegge Filter | No |
| Similarity Search | Human metabolite database | FDA approved drugs |